| Brain charts for the human lifespan RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ... Nature 604 (7906), 525-533, 2022 | 786 | 2022 |
| A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease DP Wightman, IE Jansen, JE Savage, AA Shadrin, S Bahrami, D Holland, ... Nature genetics 53 (9), 1276-1282, 2021 | 565 | 2021 |
| Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 15 (7), 888-898, 2019 | 437 | 2019 |
| White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities J Alber, S Alladi, HJ Bae, DA Barton, LA Beckett, JM Bell, SE Berman, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 351 | 2019 |
| Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium FJ Wolters, LB Chibnik, R Waziry, R Anderson, C Berr, A Beiser, JC Bis, ... Neurology 95 (5), e519-e531, 2020 | 344 | 2020 |
| Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle A Bonz, M Laser, S Küllmer, S Kniesch, J Babin-Ebell, V Popp, G Ertl, ... Journal of cardiovascular pharmacology 41 (4), 657-664, 2003 | 300 | 2003 |
| Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures MM Mielke, JA Syrjanen, K Blennow, H Zetterberg, P Vemuri, I Skoog, ... Neurology 93 (3), e252-e260, 2019 | 202 | 2019 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 196 | 2021 |
| Midlife cardiovascular fitness and dementia: a 44-year longitudinal population study in women H Hörder, L Johansson, XX Guo, G Grimby, S Kern, S Östling, I Skoog Neurology 90 (15), e1298-e1305, 2018 | 187 | 2018 |
| Cognitive and physical activity and dementia: a 44-year longitudinal population study of women J Najar, S Östling, P Gudmundsson, V Sundh, L Johansson, S Kern, ... Neurology 92 (12), e1322-e1330, 2019 | 162 | 2019 |
| The Gothenburg H70 Birth cohort study 2014–16: design, methods and study population T Rydberg Sterner, F Ahlner, K Blennow, S Dahlin-Ivanoff, H Falk, ... European journal of epidemiology 34, 191-209, 2019 | 130 | 2019 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 128 | 2022 |
| Prevalence of preclinical Alzheimer disease: Comparison of current classification systems S Kern, H Zetterberg, J Kern, A Zettergren, M Waern, K Höglund, ... Neurology 90 (19), e1682-e1691, 2018 | 112 | 2018 |
| The Gothenburg MCI study: design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up A Wallin, A Nordlund, M Jonsson, K Lind, Å Edman, M Göthlin, ... Journal of Cerebral Blood Flow & Metabolism 36 (1), 114-131, 2016 | 110 | 2016 |
| Vascular factors in suspected normal pressure hydrocephalus: a population-based study D Jaraj, S Agerskov, K Rabiei, T Marlow, C Jensen, X Guo, S Kern, ... Neurology 86 (7), 592-599, 2016 | 106 | 2016 |
| Decreasing prevalence of dementia in 85-year olds examined 22 years apart: the influence of education and stroke I Skoog, A Börjesson-Hanson, S Kern, L Johansson, H Falk, R Sigström, ... Scientific reports 7 (1), 6136, 2017 | 103 | 2017 |
| A 9-year prospective population-based study on the association between the APOE* E4 allele and late-life depression in Sweden I Skoog, M Waern, P Duberstein, K Blennow, H Zetterberg, ... Biological psychiatry 78 (10), 730-736, 2015 | 93 | 2015 |
| Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample S Kern, I Skoog, A Börjesson-Hanson, K Blennow, H Zetterberg, S Östling, ... Brain, behavior, and immunity 41, 55-58, 2014 | 93 | 2014 |
| Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression S De, DR Whiten, FS Ruggeri, C Hughes, M Rodrigues, DI Sideris, ... Acta neuropathologica communications 7, 1-13, 2019 | 90 | 2019 |
| Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment S Kern, JA Syrjanen, K Blennow, H Zetterberg, I Skoog, M Waern, ... JAMA neurology 76 (2), 187-193, 2019 | 79 | 2019 |
